S. No. Antimicrobial Control Treated G-I G-II G-III Day-5 Day-10 Day-10 1 Amikacin R R R R 2 Amoxicillin/k- clavulanate S S R S 3 Ampicillin/sulbactam S I R S 4 Ampicillin R R R S 5 Aztreonam R R R S 6 Cefazolin I I I I 7 Cefepime I I I S 8 Cefotaxime R R I S 9 Cefotetan R R R R 10 Cefoxitin R R R R 11 Ceftazidime R R R S 12 Ceftriaxone S S S S 13 Cefuroxime R R R R 14 Cephalothin R R R R 15 Chloramphenicol R R R S 16 Ciprofloxacin S S S S 17 Gatifloxacin S S S S 18 Gentamicin I I I I 19 Imipenem S S S S 20 Levofloxacin S S S S 21 Meropenem S S S S 22 Moxifloxacin S S S S 23 Nitrofurantoin R R R R 24 Norfloxacin S S S S 25 Piperacillin S S S S 26 Piperacillin/tazobactam S S S S 27 Tetracycline R R R S 28 Ticarcillin/k-clavulanate S S S S 29 Tobramycin R R R R 30 Trimethoprim/sulfamethoxazole S S S S

Table 1: Effect of biofield treatment on Shigella sonnei to antimicrobial susceptibility pattern of selected antimicrobials G, stands for group; The control group G-I and G-II were accessed on day 5 and 10; and G-III was accessed on day 10, after the biofield treatment; I, intermediate; S, susceptible; R, resistant.